Pityriasis lichenoides: Difference between revisions

From WikiMD's Wellness Encyclopedia

Deepika vegiraju (talk | contribs)
No edit summary
Tag: visualeditor-wikitext
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{SI}}
{{Infobox medical condition
| name            = Pityriasis lichenoides
| image          = [[File:PLEVA.jpg|left|thumb|Pityriasis lichenoides]]
| caption        = Pityriasis lichenoides et varioliformis acuta (PLEVA)
| synonyms        =
| pronounce      =
| specialty      = [[Dermatology]]
| symptoms        = [[Rash]], [[papules]], [[scales]]
| complications  =
| onset          =
| duration        =
| types          = [[Pityriasis lichenoides et varioliformis acuta]], [[Pityriasis lichenoides chronica]]
| causes          = Unknown
| risks          =
| diagnosis      = [[Clinical diagnosis]], [[skin biopsy]]
| differential    = [[Psoriasis]], [[lichen planus]], [[secondary syphilis]]
| prevention      =
| treatment      = [[Topical corticosteroids]], [[phototherapy]], [[antibiotics]]
| medication      =
| prognosis      =
| frequency      = Rare
}}
== '''Definition''' ==
== '''Definition''' ==
Pityriasis lichenoides (PL) is a skin condition characterized by small, raised pink spots that tend to come together in groups.
Pityriasis lichenoides (PL) is a skin condition characterized by small, raised pink spots that tend to come together in groups.
[[File:PLEVA.jpg|thumb]]
<youtube>
<youtube>
title='''{{PAGENAME}}'''
title='''{{PAGENAME}}'''
Line 12: Line 33:
height=600
height=600
</youtube>
</youtube>
== '''Cause''' ==
== '''Cause''' ==
* The exact cause of pityriasis lichenoides (PL) remains unknown.  
* The exact cause of pityriasis lichenoides (PL) remains unknown.
* Theories on the cause have included the possibility of a low-grade or self-limited [[lymphoproliferative disorder]]; a hypersensitive reaction to a bacterial or viral infection; and an inappropriate, inflammatory immune response to an unknown foreign agent.  
* Theories on the cause have included the possibility of a low-grade or self-limited [[lymphoproliferative disorder]]; a hypersensitive reaction to a bacterial or viral infection; and an inappropriate, inflammatory immune response to an unknown foreign agent.
* The most commonly reported associated infections in people with PL are [[Epstein-Barr virus (EBV)]], [[Toxoplasma gondii]], and [[human immunodeficiency virus (HIV)]].
* The most commonly reported associated infections in people with PL are [[Epstein-Barr virus (EBV)]], [[Toxoplasma gondii]], and [[human immunodeficiency virus (HIV)]].
* Other infections that have been associated with PL include [[cytomegalovirus]], [[parvovirus]] (fifth disease), [[Staphylococcus aureus]], and group A beta-haemolytic streptococci.
* Other infections that have been associated with PL include [[cytomegalovirus]], [[parvovirus]] (fifth disease), [[Staphylococcus aureus]], and group A beta-haemolytic streptococci.
Line 21: Line 41:
* However, no cause-effect relationship between PL and any of these infections or therapies has been proven.
* However, no cause-effect relationship between PL and any of these infections or therapies has been proven.
* PL is not contagious.
* PL is not contagious.
== '''Types''' ==
== '''Types''' ==
* There are two main types of PL: an acute form called '''[[pityriasis lichenoides et varioliformis acuta]] (PLEVA)''', and a milder, longer-lasting form called''' pityriasis lichenoides chronica (PLC)'''.
* There are two main types of PL: an acute form called '''[[pityriasis lichenoides et varioliformis acuta]] (PLEVA)''', and a milder, longer-lasting form called''' pityriasis lichenoides chronica (PLC)'''.
* There is also a rare, severe variant of PLEVA called febrile ulceronecrotic PLEVA, associated with high fever and complications that may affect other body systems.
* There is also a rare, severe variant of PLEVA called febrile ulceronecrotic PLEVA, associated with high fever and complications that may affect other body systems.
== '''Signs and symptoms''' ==
== '''Signs and symptoms''' ==
* In both types of PL, spots usually occur on the trunk, buttox, arms and legs.
* In both types of PL, spots usually occur on the trunk, buttox, arms and legs.
Line 31: Line 49:
* PLC may develop over days, is less irritating, and lasts longer than PLEVA.
* PLC may develop over days, is less irritating, and lasts longer than PLEVA.
* Spots associated with PLC typically fade within 3 to 4 weeks, but new spots may then appear.
* Spots associated with PLC typically fade within 3 to 4 weeks, but new spots may then appear.
* There is no clear consensus regarding how long either form of PL lasts, but most cases resolve on their own within one to several months.  
* There is no clear consensus regarding how long either form of PL lasts, but most cases resolve on their own within one to several months.
* Some cases may wax and wane, or relapse over a period of years.
* Some cases may wax and wane, or relapse over a period of years.
== '''Diagnosis''' ==
== '''Diagnosis''' ==
* This condition is diagonised based on clinical history and appearance, and the diagnosis is confirmed by skin [[biopsy]].
* This condition is diagonised based on clinical history and appearance, and the diagnosis is confirmed by skin [[biopsy]].
* The pathology of PLEVA and PLC are distinct.
* The pathology of PLEVA and PLC are distinct.
== '''Treatment''' ==
== '''Treatment''' ==
* Most cases of pityriasis lichenoides (PL) tend to resolve on their own over time.
* Most cases of pityriasis lichenoides (PL) tend to resolve on their own over time.
* However, treatment may be used to decrease the duration of the condition, especially if the rash is a nuisance.
* However, treatment may be used to decrease the duration of the condition, especially if the rash is a nuisance.
* Initial treatment for PL usually consists of topical or systemic [[corticosteroids]], or oral [[antibiotics]].  
* Initial treatment for PL usually consists of topical or systemic [[corticosteroids]], or oral [[antibiotics]].
* However, these treatments may cause multiple side effects and are not always effective.
* However, these treatments may cause multiple side effects and are not always effective.
* Natural sunlight and/or [[phototherapy]] treatment may be helpful.  
* Natural sunlight and/or [[phototherapy]] treatment may be helpful.
* A combination of tablets known as Psoralens with UVA ([[PUVA]] treatment) may also be helpful, but carries a higher risk of side effects.  
* A combination of tablets known as Psoralens with UVA ([[PUVA]] treatment) may also be helpful, but carries a higher risk of side effects.
* Severe forms of the disease may be managed by medications that suppress the immune response ([[immunosuppressants]]).
* Severe forms of the disease may be managed by medications that suppress the immune response ([[immunosuppressants]]).
{{DermNet|scaly/pityriasis-lichenoides}}
{{DermNet|scaly/pityriasis-lichenoides}}
{{Papulosquamous disorders}}
{{Papulosquamous disorders}}

Latest revision as of 12:29, 12 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Pityriasis lichenoides
Pityriasis lichenoides
Synonyms
Pronounce
Specialty Dermatology
Symptoms Rash, papules, scales
Complications
Onset
Duration
Types Pityriasis lichenoides et varioliformis acuta, Pityriasis lichenoides chronica
Causes Unknown
Risks
Diagnosis Clinical diagnosis, skin biopsy
Differential diagnosis Psoriasis, lichen planus, secondary syphilis
Prevention
Treatment Topical corticosteroids, phototherapy, antibiotics
Medication
Prognosis
Frequency Rare
Deaths N/A


Definition[edit]

Pityriasis lichenoides (PL) is a skin condition characterized by small, raised pink spots that tend to come together in groups.

Cause[edit]

  • The exact cause of pityriasis lichenoides (PL) remains unknown.
  • Theories on the cause have included the possibility of a low-grade or self-limited lymphoproliferative disorder; a hypersensitive reaction to a bacterial or viral infection; and an inappropriate, inflammatory immune response to an unknown foreign agent.
  • The most commonly reported associated infections in people with PL are Epstein-Barr virus (EBV), Toxoplasma gondii, and human immunodeficiency virus (HIV).
  • Other infections that have been associated with PL include cytomegalovirus, parvovirus (fifth disease), Staphylococcus aureus, and group A beta-haemolytic streptococci.
  • Several therapies, such as chemotherapeutic agents, estrogen-progesterone therapy, the antihistamine astemizole, certain herbs (e.g. kampo), and the measles vaccine have also been linked to the onset of PL.
  • However, no cause-effect relationship between PL and any of these infections or therapies has been proven.
  • PL is not contagious.

Types[edit]

  • There are two main types of PL: an acute form called pityriasis lichenoides et varioliformis acuta (PLEVA), and a milder, longer-lasting form called pityriasis lichenoides chronica (PLC).
  • There is also a rare, severe variant of PLEVA called febrile ulceronecrotic PLEVA, associated with high fever and complications that may affect other body systems.

Signs and symptoms[edit]

  • In both types of PL, spots usually occur on the trunk, buttox, arms and legs.
  • PLEVA begins abruptly and may cause itching or burning.
  • PLC may develop over days, is less irritating, and lasts longer than PLEVA.
  • Spots associated with PLC typically fade within 3 to 4 weeks, but new spots may then appear.
  • There is no clear consensus regarding how long either form of PL lasts, but most cases resolve on their own within one to several months.
  • Some cases may wax and wane, or relapse over a period of years.

Diagnosis[edit]

  • This condition is diagonised based on clinical history and appearance, and the diagnosis is confirmed by skin biopsy.
  • The pathology of PLEVA and PLC are distinct.

Treatment[edit]

  • Most cases of pityriasis lichenoides (PL) tend to resolve on their own over time.
  • However, treatment may be used to decrease the duration of the condition, especially if the rash is a nuisance.
  • Initial treatment for PL usually consists of topical or systemic corticosteroids, or oral antibiotics.
  • However, these treatments may cause multiple side effects and are not always effective.
  • Natural sunlight and/or phototherapy treatment may be helpful.
  • A combination of tablets known as Psoralens with UVA (PUVA treatment) may also be helpful, but carries a higher risk of side effects.
  • Severe forms of the disease may be managed by medications that suppress the immune response (immunosuppressants).

DermNet scaly/pityriasis-lichenoides


NIH genetic and rare disease info[edit]

Pityriasis lichenoides is a rare disease.


This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia